Archived News Headlines
We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.
Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.
Cancer Patients Could Face High Costs for Medications Under ObamaCare, Critics Warn
(Fox News/Associated Press) May 13, 2013 - Cancer patients could face high costs for medications under President Barack Obama's health care law, industry analysts and advocates warn.
read article 
Clinical Success Rates for New Cancer Drugs Doubled from the Mid-1990s to Early-2000s
(Tufts CSDD) May 7, 2013 - Clinical success rates for new cancer drugs doubled between the mid-1990s to the early 2000s, while the number of new cancer drugs entering clinical testing increased 50 percent during the same time, according to an analysis recently completed by the Tufts Center for the Study of Drug Development.
read press release
How Much Do Financial Interests Sway Researchers?
(Reuters Health) Apr 30, 2013 - Funding from drug companies and other potential conflicts of interest did not influence the conclusions reached by researchers testing new cancer treatments over the past few years, according to a new analysis.
read article
Study Upholds Breast Cancer Mortality for Hormone Replacement
(Los Angeles Times) Mar 30, 2013 - A new analysis of data casts doubt on earlier findings that such cancers might be less deadly.
read article (free registration required)
Study Upholds Breast Cancer Mortality for Hormone Replacement
(Los Angeles Times) Mar 30, 2013 - A new analysis of data casts doubt on earlier findings that such cancers might be less deadly.
read article (free registration required)
AP Pharma's Drug for Chemo-Induced Nausea Denied Approval
(Yahoo! News/Reuters) Mar 28, 2013 - U.S. health regulators denied approval to A.P. Pharma Inc's drug for treating chemotherapy-induced nausea and vomiting (CINV), and asked for additional analysis of late-stage data on the drug.
read article
Anal Cancer May Be on the Rise in the U.S
(Reuters Health) Mar 22, 2013 - The number of people in the U.S. with anal cancer has tripled since the 1970s, according to a new study that suggests rates of detection in high-risk groups may partly explain the rise in cases.
read article
Too Many Colonoscopies in the Elderly
(New York Times/The New Old Age blog) Mar 12, 2013 - Nearly a quarter of colonoscopies in patients over age 70 were “potentially inappropriate,” a new analysis finds.
read article
Ziopharm Proceeds with Cancer Drug Study Analysis
(BloombergBusinessweek/Associated Press) Feb 12, 2013 - Shares of Ziopharm Oncology Inc. climbed Tuesday morning after the drug developer said it will go ahead with data analysis from a late-stage trial of its lead product, the potential cancer treatment palifosfamide.
read article
Analysis: In War Against Cancer, Progress is in the Eye of the Beholder
(Reuters) Jan 7, 2013 - As the United States enters the fifth decade of its "war on cancer," deaths continue to decline, according to an exhaustive report based on official data released on Monday.
read article
Exclusive: Questionable Data Propped Up Cancer Drug Provenge
(Reuters) Oct 11, 2012 - In Dendreon Corp's most important clinical trial for the controversial cancer therapy Provenge, researchers analyzed some of the data differently from how the company told U.S. regulators they would, according to documents reviewed by Reuters.
read article
One-Third of Men With Anal Cancer Have HIV, Study Finds
(U.S. News & World Report/HealthDay News) Oct 5, 2012 - New research on anal cancer, a rare disease that's often caused by a sexually transmitted virus, found that nearly one-third of men with this form of cancer were HIV-positive.
read article
Geron Halts Phase 2 Study Of Imetelstat In Metastatic HER2negative Breast Cancer
(RTTNews) Sept 10, 2012 - Geron Corp. announced that, on the basis of an unplanned interim analysis, it is discontinuing its randomized Phase 2 study of imetelstat in metastatic HER2-negative breast cancer because median progression-free survival or PFS in the imetelstat arm was shorter than in the comparator arm.
read article
Questions Remain on Value of Robot Prostate Surgery
(Reuters) Sept 6, 2012 - Men who get robot surgery for prostate cancer have fewer short-term complications than men whose procedure is done the old-fashioned way - but the newer treatment is pricier, according to a new analysis of close to 30,000 patients.
read article
Questions Remain on Value of Robot Prostate Surgery
(Reuters) Sept 6, 2012 - Men who get robot surgery for prostate cancer have fewer short-term complications than men whose procedure is done the old-fashioned way - but the newer treatment is pricier, according to a new analysis of close to 30,000 patients.
read article
Mayo Clinic Completes First Genome-wide Analysis of Peripheral T-cell Lymphomas
(Mayo Clinic) Aug 1, 2012 - Researchers at Mayo Clinic have completed the world's first genome-wide sequencing analysis of peripheral T-cell lymphomas, unlocking the genetic secrets of this poorly understood and highly aggressive cancer of the immune system.
read press release
Serious Side Effects More Likely in New Cancer Drugs
(Reuters) July 19, 2012 - Many new cancer drugs may come at a price - including a higher risk of diarrhea, skin problems and high blood pressure, according to an analysis of studies used to get those medications approved.
read article
U.S. Mammograms Decline After Task Force Recommendation, Mayo Clinic Finds
(Mayo Clinic) June 26, 2012 - Preventive mammography rates in women in their 40s have dropped nearly 6 percent nationwide since the U.S. Preventive Services Task Force (USPSTF) recommended against routine mammograms for women in this age group, a Mayo Clinic analysis shows.
read press release
Analysis: Drug Costs Become Bigger Issue In Cancer Care
(Reuters) June 15, 2012 - In the past, money was no object when cancer specialists considered which drugs would provide the best treatment for their patients.
read article
Studies Feature New Targeted Therapies for Patients with Hard-to-Treat Cancers
(ASCO) June 2, 2012 - New studies highlighting treatment advances in platinum resistant ovarian cancer patients; promising results in a targeted immune therapy; survival trends among child and young adult leukemia patients; and analysis of patient preference for treatment in a clinical trial were released today at a press briefing at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO).
read press release
Robotic-Assisted Prostate Cancer Surgery Drives Up Costs, Despite Little Evidence of Better Outcomes for Patients, UPMC Study Find
(UPMC) May 23, 2012 - In one of the most comprehensive analyses to date of the cost of robotic-assisted, laparoscopic surgery for prostate cancer, researchers at UPMC found that this now-dominant surgical approach is significantly more costly than standard open surgery, despite little scientific evidence of long-term improved patient outcomes. The results of the study were published in the July issue of the journal Urology.
read press release
New Analysis Helps Guide Use of Erlotinib in Advanced Non-Small Cell Lung Cancer
(ESMO) Apr 18, 2012 - Patients with advanced non-small cell lung cancer should only receive treatment with the drug erlotinib before receiving standard chemotherapy if their tumor is known to harbor EGFR mutations, researchers report at the 3rd European Lung Cancer Conference in Geneva, Switzerland.
read press release
Analysis Finds Lung Cancer Screening Worthwhile For Longtime Smokers
(NPR/Shots blog) Apr 10, 2012 - Now there's fresh evidence that CT scans to detect early lung cancer belong on the short list of effective cancer screening technologies — at least for people at high risk.
read article
Nearly 800,000 Deaths Prevented Due to Declines in Smoking
(NCI) Mar 14, 2012 - Twentieth-century tobacco control programs and policies were responsible for preventing more than 795,000 lung cancer deaths in the United States from 1975 through 2000, according to an analysis funded by the National Cancer Institute (NCI), part of the National Institutes of Health.
read press release
Circumcision May Help Protect Against Prostate Cancer
(Wiley) Mar 12, 2012 - A new analysis led by researchers at Fred Hutchinson Cancer Research Center has found that circumcision before a male’s first sexual intercourse may help protect against prostate cancer.
read press release